University of Thessaly (UTH)
Πρωτόκολλο μελέτης των νεφρικών εκδηλώσεων στις ιδιοπαθείς φλεγμονώδεις εντεροπάθειες
Abstract
dc:descriptionBackground: Renal manifestations and complications are not rare in patients with inflammatory bowel disease and may present as nephrolithiasis, amyloidosis, tubulointerstitial nephritis and glomerulonephritis. Additionally, medical treatment of patients with inflammatory bowel disease such as aminosalicylates, cyclosporine and tumor necrosis factor-α inhibitors can cause renal complications.Objectives: Aim of this study was to evaluate the impact of disease and medical treatment on renal function based on several well-documented parameters as well as on some novel potential markers such as neutrophil gelatinase-associated lipocalin (NGAL). Methods: Serum and urinary NGAL, as well as urinary alpha-1-microglobulin (α1-MG) were determined in urine were determined by sandwich enzyme-linked immunosorbent assay (ELISA) in 181 IBD patients, 93 with ulcerative colitis (UC) and 88 with Crohn’s disease (CD), 82 healthy controls (HC) and 41 patients with irritable bowel syndrome (IBS). Routine and more sophisticated tools of disease activity and renal function assessment were also determined in order to fully depict all possible correlations.Results: Serum NGAL levels were elevated in IBD patients (88.19 ± 40.75 ng/mL) compared with either HC (60.06 ± 24.18 ng/mL) or IBS patients (60.80 ± 20.30 ng/mL), p<0.0001. No significant difference was shown between UC (86.62 ± 35.40 ng/mL) and CD (89.92 ± 46.05 ng/mL). Significantly higher levels of serum NGAL were observed in patients with active (120.1 ± 38.46) versus inactive IBD (61.58 ± 15.98), p<0.0001. Serum NGAL displayed strong ability to distinguish active IBD from inactive disease, healthy controls or IBS patients with a sensitivity of 100%, 95% and 95% and a specificity of 68%, 83% and 79%, respectively, performing better than ESR and CRP in the assessment of disease activity in both UC and CD. Urinary NGAL levels were 5.45 (0.6 – 77.5) ng/mL in IBD patients, 5.25 (1.2 - 74.5) ng/mL in UC and 5.9 (0.6 – 77.5) ng/mL in CD, and 5.1 (0.4 – 28) ng/mL in HC, showing no statistically significant difference (overall p = 0.577 and p > 0.05 between subgroups). Urinary NGAL was not influenced by various parameters including administration of aminosalicylates, disease activity and renal function based on serum creatinine and serum cystatin C. Urinary NGAL levels were strongly correlated with urinary α1-MG in UC, CD and HC, (p = 0.003, p = 0.009. and p = 0.002, respectively). Comclusions: Serum NGAL is up-regulated in IBD patients reflecting the degree of inflammation. However, urinary NGAL remains unaffected from bowel inflammation and is suggested as an independent and reliable marker of tubular injury, strongly correlating with urinary α1-MG. Occurrence of tubular injury in IBD patients appears to be equal to that of healthy subjects, showing no dependency either on inflammation or on medical treatment.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Oikonomou, Konstantinos
- Οικονόμου, Κωνσταντίνος
Subjects
dc:subject × 19- Ιδιοπαθείς φλεγμονώδεις εντεροπάθειες (ΙΦΕΝ)
- Ελκώδης κολίτιδα
- Νόσος Crohn
- Σύνδρομο ευερέθιστου εντέρου
- Σπειραματονεφρίτιδα
- Διάμεση σωληναριακή νεφρίτιδα
- Άλφα-1-μικροσφαιρίνη
- Inflammatory bowel diseases (IBD)
- Ulcerative colitis
- Crohn's disease
- Irritable bowel syndrome
- Glomerulonephritis
- Tubulointerstitial nephritis
- Neutrophil gelatinase-associated lipocalin
- Alpha-1-microglobulin
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33291